Sign in

CIK 0001326110

  • Large accelerated filer

ImmunityBio, Inc.

Sign in to watch
Ticker
IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
431979754
Phone
+1 844-696-5235
Business address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
Former names
NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Director sold 50,000 shares at an average $3.07 ($153,513)
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion Chairman and CEO acquired 9,257 shares (option exercise)
  5. 4 Grant or award Director acquired 27,322 shares (grant or award)
  6. 4 Grant or award Director acquired 27,322 shares (grant or award)
  7. 4 Grant or award Director acquired 27,322 shares (grant or award)
  8. 4 Open-market sale Director sold 79,456 shares at an average $3.73 ($296,225)
  9. 4 Open-market sale Director sold 2,724 shares at $3.88 ($10,564)
  10. 4 Open-market sale Director sold 6,003 shares at an average $3.94 ($23,668)
  11. 4/A Open-market sale Director sold 14,103 shares at an average $3.95 ($55,648)
  12. 4 Open-market sale Director sold 14,103 shares at an average $3.85 ($54,233)
  13. 4 Open-market sale Director sold 15,971 shares at $3.97 ($63,413)
  14. 4 Open-market sale Director sold 81,743 shares at an average $4.05 ($331,453)
  15. 4 Exercise or conversion Chief Accounting Officer acquired 15,000 shares (option exercise)
  16. 4 Gift Director gave 4,500 shares (gift)
  17. 4 Grant or award Director acquired 54,621 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Director sold 39,604 shares at $5.93 ($234,729)
  20. 4 Open-market sale Director sold 103,841 shares at an average $6.04 ($627,417)

Page 10 of 13 · 251 filings